Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Legionnaires' Disease | 1 | 2024 | 50 | 0.930 |
Why?
|
Viruses | 3 | 2024 | 371 | 0.870 |
Why?
|
Rhabdomyolysis | 1 | 2024 | 150 | 0.850 |
Why?
|
Confusion | 1 | 2024 | 278 | 0.800 |
Why?
|
Drug Labeling | 1 | 2024 | 251 | 0.760 |
Why?
|
Influenza, Human | 3 | 2024 | 1543 | 0.720 |
Why?
|
Arbovirus Infections | 1 | 2020 | 21 | 0.720 |
Why?
|
Community-Acquired Infections | 1 | 2024 | 470 | 0.700 |
Why?
|
West Nile Fever | 1 | 2020 | 77 | 0.700 |
Why?
|
West Nile virus | 1 | 2020 | 77 | 0.700 |
Why?
|
Anti-Bacterial Agents | 9 | 2024 | 7469 | 0.690 |
Why?
|
Microbial Sensitivity Tests | 3 | 2024 | 1969 | 0.690 |
Why?
|
Metagenome | 2 | 2021 | 464 | 0.640 |
Why?
|
Central Nervous System Infections | 1 | 2019 | 61 | 0.630 |
Why?
|
Renal Insufficiency | 1 | 2024 | 812 | 0.620 |
Why?
|
Drug Resistance, Bacterial | 4 | 2024 | 1063 | 0.610 |
Why?
|
Daptomycin | 1 | 2018 | 71 | 0.600 |
Why?
|
Urinary Tract Infections | 2 | 2022 | 804 | 0.590 |
Why?
|
Enterococcus faecium | 1 | 2018 | 101 | 0.580 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2019 | 453 | 0.500 |
Why?
|
Molecular Epidemiology | 1 | 2017 | 473 | 0.500 |
Why?
|
Pandemics | 10 | 2023 | 8736 | 0.490 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 986 | 0.440 |
Why?
|
Metagenomics | 3 | 2023 | 473 | 0.420 |
Why?
|
Influenza Vaccines | 1 | 2020 | 780 | 0.420 |
Why?
|
Bacteremia | 1 | 2018 | 983 | 0.380 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3112 | 0.360 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3234 | 0.350 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1429 | 0.330 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1396 | 0.310 |
Why?
|
Clinical Laboratory Techniques | 3 | 2020 | 746 | 0.270 |
Why?
|
Systems Biology | 1 | 2010 | 481 | 0.270 |
Why?
|
Respiratory Syncytial Viruses | 2 | 2024 | 168 | 0.250 |
Why?
|
Legionella pneumophila | 1 | 2024 | 50 | 0.230 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2010 | 1137 | 0.230 |
Why?
|
Genome, Bacterial | 2 | 2021 | 796 | 0.230 |
Why?
|
Vibrio cholerae | 1 | 2010 | 793 | 0.230 |
Why?
|
Metapneumovirus | 1 | 2024 | 28 | 0.230 |
Why?
|
Paramyxoviridae Infections | 1 | 2024 | 57 | 0.220 |
Why?
|
Disease Outbreaks | 2 | 2023 | 1761 | 0.200 |
Why?
|
Cryptococcus neoformans | 1 | 2022 | 110 | 0.200 |
Why?
|
Cryptococcosis | 1 | 2022 | 99 | 0.200 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 148 | 0.190 |
Why?
|
Seasons | 3 | 2023 | 1523 | 0.190 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.190 |
Why?
|
Serologic Tests | 2 | 2020 | 382 | 0.190 |
Why?
|
Carbapenems | 1 | 2022 | 125 | 0.180 |
Why?
|
Tuberculosis, Lymph Node | 1 | 2020 | 21 | 0.180 |
Why?
|
Humans | 44 | 2024 | 767040 | 0.180 |
Why?
|
Shigella | 1 | 2021 | 69 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3667 | 0.170 |
Why?
|
Lymphadenitis | 1 | 2020 | 99 | 0.170 |
Why?
|
Meningitis | 1 | 2021 | 219 | 0.170 |
Why?
|
Gentian Violet | 1 | 2019 | 25 | 0.170 |
Why?
|
Phenazines | 1 | 2019 | 53 | 0.160 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 166 | 0.160 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12986 | 0.160 |
Why?
|
Acyclovir | 1 | 2019 | 267 | 0.150 |
Why?
|
Immune Evasion | 1 | 2022 | 375 | 0.150 |
Why?
|
Sepsis | 2 | 2023 | 2605 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 366 | 0.150 |
Why?
|
Herpesvirus 3, Human | 1 | 2019 | 159 | 0.150 |
Why?
|
Income | 1 | 2006 | 1877 | 0.150 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2019 | 667 | 0.150 |
Why?
|
Virus Diseases | 1 | 2024 | 722 | 0.140 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 831 | 0.140 |
Why?
|
Encephalitis | 1 | 2021 | 441 | 0.140 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2018 | 45 | 0.140 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2018 | 48 | 0.140 |
Why?
|
Bacterial Proteins | 1 | 2010 | 3834 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2019 | 252 | 0.130 |
Why?
|
Propensity Score | 1 | 2024 | 1971 | 0.130 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3212 | 0.130 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2021 | 592 | 0.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2024 | 705 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1009 | 0.130 |
Why?
|
Vancomycin | 1 | 2018 | 504 | 0.120 |
Why?
|
Endocarditis, Bacterial | 1 | 2019 | 436 | 0.120 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1044 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 862 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 2011 | 0.120 |
Why?
|
Viral Load | 2 | 2021 | 3385 | 0.120 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4780 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1518 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9532 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 923 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 788 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1379 | 0.100 |
Why?
|
Outpatients | 1 | 2020 | 1600 | 0.100 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7848 | 0.090 |
Why?
|
Adult | 14 | 2024 | 223317 | 0.090 |
Why?
|
Elephantiasis, Filarial | 2 | 2007 | 31 | 0.090 |
Why?
|
Middle Aged | 15 | 2024 | 223233 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2160 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2024 | 5345 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6067 | 0.080 |
Why?
|
Diethylcarbamazine | 2 | 2007 | 23 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1911 | 0.080 |
Why?
|
Male | 16 | 2024 | 364203 | 0.080 |
Why?
|
Albendazole | 2 | 2007 | 51 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2020 | 3468 | 0.080 |
Why?
|
Bacteriological Techniques | 1 | 2010 | 277 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7063 | 0.080 |
Why?
|
United States | 7 | 2023 | 72971 | 0.080 |
Why?
|
Incidence | 3 | 2023 | 21526 | 0.080 |
Why?
|
Culture Media | 1 | 2010 | 892 | 0.070 |
Why?
|
Cholera Toxin | 1 | 2010 | 562 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2024 | 81659 | 0.070 |
Why?
|
Anthelmintics | 1 | 2007 | 83 | 0.070 |
Why?
|
Female | 14 | 2024 | 396660 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3070 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.070 |
Why?
|
Virulence | 1 | 2010 | 1294 | 0.070 |
Why?
|
Plasmids | 2 | 2022 | 2268 | 0.070 |
Why?
|
Filaricides | 1 | 2005 | 10 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2019 | 12451 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9360 | 0.060 |
Why?
|
Texas | 1 | 2024 | 410 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20741 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2010 | 2721 | 0.050 |
Why?
|
Aged | 9 | 2024 | 171319 | 0.050 |
Why?
|
Rhinovirus | 1 | 2024 | 209 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3797 | 0.050 |
Why?
|
Health Services | 1 | 2007 | 755 | 0.050 |
Why?
|
Candida | 1 | 2022 | 171 | 0.050 |
Why?
|
Eye Diseases | 1 | 2007 | 660 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15925 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2023 | 389 | 0.050 |
Why?
|
Macrolides | 1 | 2022 | 204 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2022 | 505 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 15645 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5716 | 0.040 |
Why?
|
Program Evaluation | 2 | 2007 | 2505 | 0.040 |
Why?
|
Health Resources | 1 | 2007 | 948 | 0.040 |
Why?
|
Groin | 1 | 2020 | 106 | 0.040 |
Why?
|
Dysentery, Bacillary | 1 | 2021 | 73 | 0.040 |
Why?
|
Purpura | 1 | 2020 | 117 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14098 | 0.040 |
Why?
|
Cross Reactions | 1 | 2022 | 828 | 0.040 |
Why?
|
Hypercholesterolemia | 1 | 2006 | 1144 | 0.040 |
Why?
|
Adenoviridae | 1 | 2024 | 1092 | 0.040 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2020 | 234 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 621 | 0.040 |
Why?
|
Educational Status | 1 | 2006 | 2511 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2007 | 1405 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 404 | 0.040 |
Why?
|
Penicillins | 1 | 2022 | 404 | 0.040 |
Why?
|
Prevalence | 2 | 2024 | 15851 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 2019 | 303 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26325 | 0.040 |
Why?
|
Antibody Formation | 1 | 2023 | 1392 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1566 | 0.040 |
Why?
|
Diabetic Retinopathy | 1 | 2007 | 1300 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 74886 | 0.040 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.040 |
Why?
|
Social Class | 1 | 2006 | 2007 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 645 | 0.040 |
Why?
|
Brain | 1 | 2024 | 27163 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1947 | 0.030 |
Why?
|
Respiratory System | 1 | 2020 | 563 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2024 | 1390 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
Child | 2 | 2024 | 80771 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1836 | 0.030 |
Why?
|
Health Promotion | 1 | 2007 | 2210 | 0.030 |
Why?
|
Specimen Handling | 1 | 2020 | 706 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2526 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1006 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1020 | 0.030 |
Why?
|
Cross Infection | 1 | 2024 | 1426 | 0.030 |
Why?
|
Haiti | 2 | 2007 | 553 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1477 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 673 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1320 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2022 | 1893 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4572 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1172 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2021 | 1344 | 0.030 |
Why?
|
Models, Molecular | 1 | 2022 | 5388 | 0.020 |
Why?
|
Learning | 1 | 2021 | 1754 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5456 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8890 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2212 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2024 | 3797 | 0.020 |
Why?
|
Length of Stay | 1 | 2024 | 6489 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3434 | 0.020 |
Why?
|
Primary Health Care | 1 | 2007 | 4746 | 0.020 |
Why?
|
Smoking | 1 | 2006 | 9081 | 0.020 |
Why?
|
Animals | 2 | 2020 | 168965 | 0.020 |
Why?
|
Escherichia coli | 1 | 2022 | 4209 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9327 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3561 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2007 | 5519 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6777 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1592 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6844 | 0.020 |
Why?
|
Time Factors | 1 | 2010 | 40154 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4256 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5886 | 0.020 |
Why?
|
Elephantiasis | 1 | 2007 | 11 | 0.020 |
Why?
|
Philippines | 1 | 2007 | 95 | 0.020 |
Why?
|
Dominican Republic | 1 | 2007 | 78 | 0.020 |
Why?
|
Egypt | 1 | 2007 | 100 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2681 | 0.020 |
Why?
|
Burkina Faso | 1 | 2007 | 88 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54886 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8615 | 0.020 |
Why?
|
Ghana | 1 | 2007 | 333 | 0.020 |
Why?
|
Wuchereria bancrofti | 1 | 2005 | 20 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 89046 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 6210 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12823 | 0.010 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6550 | 0.010 |
Why?
|
Sentinel Surveillance | 1 | 2005 | 292 | 0.010 |
Why?
|
Government Programs | 1 | 2005 | 278 | 0.010 |
Why?
|
Tanzania | 1 | 2007 | 1406 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2007 | 1666 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42606 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36485 | 0.010 |
Why?
|
Ophthalmology | 1 | 2007 | 560 | 0.010 |
Why?
|
Health Services Research | 1 | 2007 | 1815 | 0.010 |
Why?
|
Research | 1 | 2007 | 1977 | 0.010 |
Why?
|
Health Education | 1 | 2005 | 1058 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59980 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30211 | 0.010 |
Why?
|
Health Surveys | 1 | 2007 | 4056 | 0.010 |
Why?
|
Patient Care Team | 1 | 2007 | 2516 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6310 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2007 | 1945 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 10393 | 0.010 |
Why?
|
Concepts
(234)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(91)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_